Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Biochem Funct ; 26(8): 874-80, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18946876

RESUMEN

Here we investigated the effect of lifelong supplementation of the diet with coconut fat (CO, rich in saturated fatty acids) or fish oil (FO, rich in n-3 polyunsaturated fatty acids) on tumor growth and lactate production from glucose in Walker 256 tumor cells, peritoneal macrophages, spleen, and gut-associated lymphocytes. Female Wistar rats were supplemented with CO or FO prior to mating and then throughout pregnancy and gestation and then the male offspring were supplemented from weaning until 90 days of age. Then they were inoculated subcutaneously with Walker 256 tumor cells. Tumor weight at 14 days in control rats (those fed standard chow) and CO supplemented was approximately 30 g. Supplementation of the diet with FO significantly reduced tumor growth by 76%. Lactate production (nmol h(-1) mg(-1) protein) from glucose by Walker 256 cells in the group fed regular chow (W) was 381.8 +/- 14.9. Supplementation with coconut fat (WCO) caused a significant reduction in lactate production by 1.6-fold and with fish oil (WFO) by 3.8-fold. Spleen lymphocytes obtained from W and WCO groups had markedly increased lactate production (553 +/- 70 and 635 +/- 150) when compared to non-tumor-bearing rats ( approximately 260 +/- 30). FO supplementation reduced significantly the lactate production (297 +/- 50). Gut-associated lymphocytes obtained from W and WCO groups increased lactate production markedly (280 +/- 31 and 276 +/- 25) when compared to non-tumor-bearing rats ( approximately 90 +/- 18). FO supplementation reduced significantly the lactate production (168 +/- 14). Lactate production by peritoneal macrophages was increased by tumor burden but there was no difference between the groups fed the various diets. Lifelong consumption of FO protects against tumor growth and modifies glucose metabolism in Walker tumor cells and lymphocytes but not in macrophages.


Asunto(s)
Carcinoma 256 de Walker/metabolismo , Ácidos Grasos Omega-3/administración & dosificación , Aceites de Pescado/administración & dosificación , Linfocitos/metabolismo , Macrófagos/metabolismo , Análisis de Varianza , Animales , Carcinoma 256 de Walker/dietoterapia , Suplementos Dietéticos , Ácidos Grasos Omega-3/farmacología , Femenino , Aceites de Pescado/farmacología , Ácido Láctico/sangre , Masculino , Embarazo , Efectos Tardíos de la Exposición Prenatal , Ratas , Ratas Wistar , Células Tumorales Cultivadas
2.
Mol Cell Biochem ; 273(1-2): 145-50, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-16013449

RESUMEN

The insulin-like effects of peroxovanate (POV) and peroxovanadyl (PSV) on rates of lactate formation and glycogen synthesis were measured in isolated incubated soleus muscle preparations. In another experiment rats were made insulin deficient by streptozotocin injection and treated with POV and PSV (0.25 mM) administered in the drinking water and in the course of 7 days glycemia were determined. Also, signal transduction proteins ERK 1 and ERK 2 involved in the insulin signaling were measured in soleus muscle of diabetic rats treated with POV and PSV. Peroxides of vanadate and vanadyl significantly stimulated glucose utilization in soleus muscle preparations in vitro. The stimulation of glycogen synthesis and lactate formation by POV and PSV was similar to insulin stimuli. Rats treated with POV or PSV presented reduction of glycemia, food and fluid intake with amelioration of the diabetic state during the short period of treatment (7 days). POV and PSV modulated ERK1/2 phosphorilation and the insulin administration in these rats caused an addictive effect on phosphorilation state of these proteins.


Asunto(s)
Glucosa/metabolismo , Hipoglucemiantes/farmacología , Músculo Esquelético/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Vanadatos/farmacología , Compuestos de Vanadio/farmacología , Animales , Diabetes Mellitus Experimental/etiología , Diabetes Mellitus Experimental/metabolismo , Glucógeno/metabolismo , Hiperglucemia/etiología , Hiperglucemia/fisiopatología , Insulina/farmacología , Ácido Láctico/metabolismo , Masculino , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Músculo Esquelético/citología , Músculo Esquelético/metabolismo , Fosforilación/efectos de los fármacos , Ratas , Ratas Wistar , Compuestos de Vanadio/química
3.
Acta sci., Health sci ; 27(1): 45-48, jan.-jun. 2005. graf
Artículo en Portugués | LILACS | ID: lil-431712

RESUMEN

As folhas de carambola (Averrhoa carambola L.) são utilizadas na fabricação do fitoterápico Glico-Vitae®, indicado no tratamento do diabetes melittus tipo 2. Em nossos estudos, ratos machos Wistar que receberam, por via intragástrica, o extrato bruto liofilizado (EC) e as frações de EC (20 mg/kg), durante duas semanas, apresentaram redução da glicemia. Mas, diferentemente da insulina, o EC e suas frações não estimularam a síntese de glicogênio e a produção de lactato em músculo sóleo isolado. Da fração mais ativa, empregando métodos espectroscópicos de EM, RMN1H e RMN13C, foram isoladas três frações semipurificadas majoritárias e, por comparação com os dados da literatura, foram identificadas como misturas complexas de açúcares


Asunto(s)
Animales , Ratas , Hipoglucemiantes/análisis , Hipoglucemiantes/farmacocinética , Hipoglucemiantes/farmacología , Fitoterapia , Extractos Vegetales , Plantas Medicinales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA